ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Designated persons and the company's Employee Welfare Trust disclosed multiple equity transactions, including ESOP exercises and market sales, in a recent regulatory filing.
Dr. Lal PathLabs reported insider trading disclosures for share sales by a designated person and the Employee Welfare Trust. These trades involve 33,350 shares total.
Dr. Lal PathLabs has allotted 2,11,050 equity shares under its Employee Stock Option Plan 2022. This issuance increases the company's total paid-up equity share capital.
Dr. Lal Path Labs has granted 119,300 stock options to eligible employees under its 2025 Restricted Stock Unit Plan.
Dr. Lal Path Labs Ltd. allotted 82,750 equity shares on April 30, 2026, following the exercise of options under its Employee Stock Option Plan 2022. This allotment increases the company's paid-up share capital to 167,637,770 shares.